Australia to begin human trials for COVID-19 vaccine made by China
Category: #headlines  By Saipriya Iyer  Date: 2020-04-29
  • share
  • Twitter
  • Facebook
  • LinkedIn
Australia to begin human trials for COVID-19 vaccine made by China

Linear Clinical Research, a research and clinical facility in Perth, Australia, has confirmed a human trial of a coronavirus vaccine that has been developed by China. Sources familiar with the matter said that research and clinical facility has already initiated the recruitment of healthy adults to participate in the trial within the coming two months.

S-Trimer vaccine, which is primarily developed by a biotechnology company called Clover Biopharmaceuticals, located in China, is believed to be one of the first COVID-19 vaccines to be under development. Linear had also made an announcement regarding the vaccine trial on the website and also called on the people who are interested in being registered with the company.

The company issued the statement that if people were feeling unhealthy and were located in Perth, WA, they could register their interest to be able to participate in the forthcoming COVID-19 vaccine study of the company.

According to a reliable source, the protein-based vaccine S-Trimer, is aimed at helping the body in producing anti-bodies to fight the virus.

Jayden Rogers, Linear’s chief executive commented that the trial was among the most vital trials across the globe and involves some extremely renowned vaccine firms. The S-Trimer vaccine had shown promising potential on the trial and has been placed at the forefront of the world’s battle with coronavirus pandemic.

The Chinese authorities had approved the human testing for two other COVID-19 vaccines recently in the month of April that were developed by the Wuhan Institute of Biological Products. This was done under the Sinovac Research and Development Co and China National Pharmaceutical Group (Sinopharm).

Apparently, Sinopharm has been able to produce more than 50,000 doses for the clinical trials. Once the production gets normalized, the output is capable of reaching about 3 million doses per batch and an annual output would be at 100 million doses.

 

Source Credit- https://www.aa.com.tr/en/asia-pacific/australia-set-for-chinese-covid-19-vaccine-human-trial-/1821328

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Saipriya Iyer

Saipriya Iyer    

Saipriya Iyer currently works as a content developer for GroundAlerts. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had previous experience of 3 years under her belt, she has dabbled with website ...

Read More >>

More News By Saipriya Iyer

Australian govt inks deal with 3 key gas exporters to avoid shortfalls
Australian govt inks deal with 3 key gas exporters to avoid shortfalls
By Saipriya Iyer

The Australian government has reportedly reached an agreement with the three leading east coast gas suppliers to ensure that an adequate supply of fossil energy is available to avert any possible shortage next year. Madeleine King, the federal res...

Chinese Yuan hits a new low against surging US dollar
Chinese Yuan hits a new low against surging US dollar
By Saipriya Iyer

The Chinese yuan has reportedly depreciated to a record low in relation to the rising US dollar. The yuan, which is traded internationally, plunged to its lowest level since data started to be made accessible in 2011. The value of the local cur...

British MPs: Energy bills to rise if Drax gets more government support
British MPs: Energy bills to rise if Drax gets more government support
By Saipriya Iyer

MPs from the UK have reportedly cautioned that if the government jumps into giving power station operator Drax more state support, people may find themselves paying higher energy bills. Nuclear and renewable power generators are being encouraged t...